Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes.
Saved in:
| Title: | Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes. |
|---|---|
| Authors: | Shteinman ER; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Attrill GH; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Maher NG; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Gnana K; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Addala V; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Mao Y; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Palendira U; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Conway JW; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Waddell N; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Hayward NK; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Pearson JV; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; Mater Hospital, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au. |
| Source: | Genome medicine [Genome Med] 2026 May 26; Vol. 18 (1). Date of Electronic Publication: 2026 May 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
